Mai-Britt Worm Ørntoft retweeted
'The Art of trust'. Outstanding public PhD defence by @KHesseldal on the supervisor perspective in surgical training. The ARTS phramework is here to stay. Congrats. @lapcoleadmark
@runedalljensen
@AuHsurgery
@morntoft
Mai-Britt Worm Ørntoft retweeted
👨🎓@JesperNors will defend his PhD "Colorectal Cancer Recurrence: Algorithmic identification using national administrative data and estimation of incidence during and after postoperative surveillance in Denmark" at @HealthAarhusUni on May, 3rd.
More at: linkedin.com/posts/moma-auh_…
Mai-Britt Worm Ørntoft retweeted
Godt at opfølgningen efter kræft kommer til at have patienten i centrum og ikke blot være et kalenderstyret standardforløb!
Godt arbejde @ThereseJuul 👍🏻
Meget af den kontrol vi laver stammer fra en tid, hvor patienterne havde dårligere prognose. avisendanmark.dk/indland/kra…
Mai-Britt Worm Ørntoft retweeted
Great talk by Nadia Øgaard @GaardNadia on lower shedding of tumor DNA by Asymptomatic than symptomatic CRC tumors
@CNAPS2024 in Graz Austria
Mai-Britt Worm Ørntoft retweeted
What happens to our immune system as we age?
Assoc. prof. Nicolai Birkbak @nbirkbak at @HealthAarhusUni has received ~ DKK 10 mill. from @novonordiskfond Data Science for the project "Unravelling Immunosenescence from Single Cell and Spatial data"
datascience.novonordiskfonde…
Mai-Britt Worm Ørntoft retweeted
Stor dag hos @AuHsurgery når @Ginibala forsvarer sin PhD om senfølger til avanceret tyk-og endetarmskræft fredag 2/2 2024 kl 14.30. phd.health.au.dk/display/art…
@LeneHjerrild @PeterCh12345
@henrthay @DCCCcancer
@cancer_dk #ikkealeneefterkræft
Mai-Britt Worm Ørntoft retweeted
DCCC's pulje har i år støttet i alt 16 initiativer - de spænder fra forberedelse af studier over etablering af netværk til udbredelse af viden inden for kræftområdet. Læs om puljen og de seneste 3 initiativer, vi netop har støttet: urlis.net/r5s1cxrj -næste frist: 1/2-24.
Mai-Britt Worm Ørntoft retweeted
BLODPRØVE KAN HJÆLPE MED PRIORITERING AF KRÆFTBEHANDLING
Kræft-DNA i blodet hos patienter med de meste aggressive kræftformer stiger meget hurtigt.
Blodprøver kan være et redskab til prioritering af operationskapacitet på kræftområdet.
linkedin.com/posts/aarhus-un…
📷Jens Løgstrup
Mai-Britt Worm Ørntoft retweeted
New study out!
#Intraoperative intestinal #perfusion assessment - a matter of objectivity!
doi.org/10.1159/000535525
Rupan Paramasivam, Rikard Ambrus, Marie Stavsetra, @morntoft , @ahustedmadsen
#surgery #intestines #microcirculation #LSCI #porcinemodel
Mai-Britt Worm Ørntoft retweeted
New paper out in @Annals_Oncology 🧬📢
Great work by @TennaVesterman and the research team of @ClausLindbjerg 🙌
👉 Read the article here: annalsofoncology.org/article…
#ctDNA #CancerResearch
📢 Our newest study on >800 CRC patients is now out 🧬
Read how:
1) Serial ctDNA = powerful recurrence predictor ⏳
2) Rapid ctDNA growth = detrimental to survival 📈
3) Personalized digital PCR = clinically practical for MRD analysis💡
🔗 Read more in @AnnalsofOncology! 📰
Mai-Britt Worm Ørntoft retweeted
Today I had the great pleasure of chairing the oral presentations in the colorectal session at the annual meeting at the Danish Surgical Society together with the lovely ladies @morntoft and @susannehaas9
Thank you for many exciting talks!
Mai-Britt Worm Ørntoft retweeted
New paper just out in @JAMAOncology
- The treatment of CRC has improved dramatically from 2004-2019.
Amazing work by @JesperNors
@SunesenKG @LeneHjerrild @RuneErichsen
Incidence of Recurrence and Time to Recurrence in Stage I to III Colorectal Cancer jamanetwork.com/journals/jam…
Mai-Britt Worm Ørntoft retweeted
Replying to @AnneMartensen
@AnneMartensen med de præliminære resultater af STIMULATE - er elektrisk stimulation mon fremtiden til behandling af postoperativ ileus?⚡️ @jonas_funder @MetteMoellerS @LeneHjerrild
Mai-Britt Worm Ørntoft retweeted
Laser epilation (LE) as an adjunct to standard care significantly reduce 1-year recurrence rates compared to standard care alone. LE is safe and well-tolerated in patients with pilonidal disease. ja.ma/3QQFkeD @PeteMinneciMD @lindsaygil6 @KateDeansMD
Mai-Britt Worm Ørntoft retweeted
Og vi fik pitched projekter i “Løvens hule” 🦁- en eye opener og meget lærerigt. Interdisciplinært #samarbejde👍
På dag 2 om “Ny Teknologi” får vi indblik i processen fra ide til realisering, hvor investorer og entrepreneurer fortæller om medicinsk innovation 👏🏻 @DCCCcancer @cancer_dk
Mai-Britt Worm Ørntoft retweeted
Og ny teknologi inkl robotics, AI, kan fungere som et redskab, en assistent og en samarbejdspartner - hurra for forskning og udvikling 🙏
Hvordan forholder vi os til ny teknologi i klinisk forskning? Lærerige oplæg til CFA2 internat i dag om ‘next generation deep evidence-based medicine’ - også fra et antropologisk perspektiv @cancer_dk @DCCCcancer
Mai-Britt Worm Ørntoft retweeted
NEW RENAL CANCER RESEARCH GROUP AT MOMA 🚀
Iben Lyskjær Heimann @Ilyskjaer has recently started a renal cancer research group. 👩🔬 💪
The team will identify new biomarkers for #renalcancer recurrence, #immunotherapy, residual disease or relapse.
Read more: linkedin.com/posts/moma-auh_…
Iben Lyskjær, Adjunkt ved Institut for Klinisk Medicin, @AarhusUni , har af Lundbeckfonden fået et #fellowship på i alt 10 mio. kr.
Hun vil fokusere på at identificere nye biomarkører, der kan bestemme risikoen for tilbagefald af kræft.
Læs: lundbeckfonden.com/harnessin…
#dkforsk
Mai-Britt Worm Ørntoft retweeted
Welcome @ClausLindbjerg, director of the “National Danish Research Centre for circulating tumor DNA guided treatment”, as a speaker at #cnaps2024. His research focuses on translation of basic molecular cancer knowledge into clinical tools.
Mai-Britt Worm Ørntoft retweeted
Skal du med til vores kommende internat omhandlende “Ny Teknologi”. Så lyt med og registrér dig her: Acrobatic.dk/Acrobatic-cfa2-… @DCCCcancer @cancer_dk
































